Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide plus Bendamustine in Relapsed/Refractory Hodgkin Lymphoma
NCT01412307Phase 2Unknown
- Sponsor
- Istituto Nazionale Tumori IRCCS Fondazione Pascale
- Start
- Jul 2011
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in Hodgkin lymphoma (HL), sponsored by Istituto Nazionale Tumori IRCCS Fondazione Pascale. Status: unknown.
02
Drugs
lenalidomide
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT01412307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01412307.